Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Peringkat dalam Saham #32158
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Harga Saham
$0.05504527
Terakhir disinkronkan: 2026-08-17
Kapitalisasi Pasar
$10.89M
Perubahan (1 hari)
15.38%
Perubahan (1 tahun)
-10.64%
Negara
CA
Perdagangan Hemostemix Inc. (HEM)

Kategori

Riwayat harga saham Hemostemix Inc. (HEM)
Harga penutupan tertinggi: $0.05 pada 2026-08-01

Harga penutupan terendah: $13.17 pada 2014-11-01
Riwayat harga saham Hemostemix Inc. dari 2014 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -3.76%
2025 16.47%
2024 0.85%
2023 -52.75%
2022 -7.37%
2021 -60.16%
2020 105.00%
2019 -89.61%
2018 12.43%
2017 -27.92%
2016 -79.94%
2015 -39.73%
2014 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$515.58 32.24%
US
$992.01 50.00%
NL
$112.11 -36.37%
AU
$736.64 6.99%
CH
$1.06K -6.98%
KR